Europe Microneedle Drug Delivery Systems Market Size

Europe Microneedle Drug Delivery Systems Market Size 2027

Europe Microneedle Drug Delivery Systems Market By Type (Hollow, Dissolving, Solid, Coated, and Other Types), By Material (Metal, Polymer, Silicon and Other Material), By Application (Drug delivery, Cancer Therapy, Vaccine delivery, Pain Management, Dermatology and Other Applications), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : November-2021 | Number of Pages : 93 | Format : PDF

COVID-19

Get in-depth analysis of the COVID-19 impact on the Europe Microneedle Drug Delivery Systems Market

Market Report Description

The Europe Microneedle Drug Delivery Systems Market would witness market growth of 7.4% CAGR during the forecast period (2021-2027).

The microneedle drug delivery systems have found their application across various fields like cancer therapy, pain management, cosmetics, vaccine administration, and hormonal delivery. Moreover, various new microneedle products are emerging in the market. Before launching the new microneedles into the market, they must be researched to meet several challenges.

The vaccine or drug delivery through microneedles is considered to be the best approach in comparison to the conventional hypodermic injections. Moreover, microneedle is a self-administering platform for the delivery of transdermal medication, which has excessive drug bioavailability. Further, the design of the microneedle and drug formulation can regulate delivery rate, the efficacy of the medications, and dose. Additionally, these microneedles eliminate the biohazardous sharps waste. Therefore, it is anticipated that microneedles would have a positive impact on clinical care.

The growth of the European microneedle drug delivery systems market would be boosted by the fact that governments of different countries of this region is undertaking various initiatives like the national initiative of Germany with an aim to promote microneedle drug delivery systems awareness. The patients residing in the region are highly adopting microneedle drug delivery systems in order to deliver the vaccine, nutrients, and other required elements. Thus, the regional population prefers this method significantly due to its various benefits.

In 2020, the European Society for Clinical Nutrition and Metabolism formulated the regulations regarding the nutritional management of individuals infected with the coronavirus. According to the article circulated in 2020, the coronavirus led to a significant absence of appetite along with other symptoms that result in loss of muscle mass and a weakening immune response. To tackle this situation, clinics and hospitals have increased the accessibility of healthcare facilities for patients that need sufficient nutrition administration. These developments are anticipated to boost the demand & adoption of microneedle drug delivery systems across this region.

The Germany market dominated the Europe Vaccine delivery Market by Country in 2020, thereby, achieving a market value of $114 million by 2027. The UK market is exhibiting a CAGR of 6% during (2021 - 2027). Additionally, The France market is poised to witness a CAGR of 8.3% during (2021 - 2027).

Based on Type, the market is segmented into Hollow, Dissolving, Solid, Coated, and Other Types. Based on Material, the market is segmented into Metal, Polymer, Silicon and Other Material. Based on Application, the market is segmented into Drug delivery, Cancer Therapy, Vaccine delivery, Pain Management, Dermatology and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Microneedle Drug Delivery Systems Market Size will Hit $9.1 Billion by 2027, at a CAGR of 7.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AdminMed nanoBioSciences LLC, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Technologies Ltd., Corium International, Inc., Gurnet Point Capital), Valeritas, Inc. (Zealand Pharma), Nitto Denko Corporation, Endoderma Ltd., and Innoture Medical Technology Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Hollow
  • Dissolving
  • Solid
  • Coated,
  • Other Types

By Material

  • Metal
  • Polymer
  • Silicon
  • Other Material

By Application

  • Drug delivery
  • Cancer Therapy
  • Vaccine delivery
  • Pain Management
  • Dermatology
  • Other Applications

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • AdminMed nanoBioSciences LLC
  • Becton, Dickinson and Company
  • Zosano Pharma Corporation
  • Raphas co. ltd.
  • Nanopass Technologies Ltd.
  • Corium International, Inc. (Gurnet Point Capital)
  • Valeritas, Inc. (Zealand Pharma)
  • Nitto Denko Corporation
  • Endoderma Ltd.
  • Innoture Medical Technology Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Microneedle Drug Delivery Systems Market Report 2021-2027

North America Microneedle Drug Delivery Systems Market Report 2021-2027

Asia Pacific Microneedle Drug Delivery Systems Market Report 2021-2027

LAMEA Microneedle Drug Delivery Systems Market Report 2021-2027

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities